Breaking Pregnancy Taboos recently hit a milestone with the creation of our advisory board. We are proud to introduce the first four advisory board members, each one having shown a keen interest or expertise in the field of pregnancy and medication. We welcome Dr. Frédéric Amant, Head of Gynecologic Oncology at the University of Leuven; Dr. Aparna Kamat, an…
Month: January 2014
Digging deeper: how the OPRU is uncovering pregnancy taboos
There’s no question that healthcare professionals and mothers-to-be have many questions when it comes to taking medicines during pregnancy. So who’s breaking new ground in the search for answers to these questions? The Obstetric-Fetal Pharmacology Research Units Network is one organization. It’s a network of sites across four US universities that investigate the effects of drugs in pregnant and breastfeeding…
Read more > Digging deeper: how the OPRU is uncovering pregnancy taboos
Reading the small print: drug labeling and pregnancy
When it comes to drug labeling, the small print is vitally important. It tells us what to expect when we take a medicine. It reminds us of who should take it, and how often, and what to do if something goes wrong. And there’s an important regulatory side to it as well: pharma firms have to make sure that their…
Read more > Reading the small print: drug labeling and pregnancy
